Biocryst Pharmaceuticals reported $41.49M in Trade Debtors for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
DBV Technologies DBVT:US 8.21M 3.7M
Alnylam Pharmaceuticals ALNY:US $ 142.27M 14.26M
Biocryst Pharmaceuticals BCRX:US $ 41.49M 5.08M
Chemocentryx CCXI:US $ 4.95M 2.14M
Chugai Pharma 4519:JP Y 268897M 122401M
Daiichi Sankyo 4568:JP Y 291037M 24362M
Enanta Pharmaceuticals ENTA:US $ 48.21M 0.74M
Gilead Sciences GILD:US $ 4118M 331M
Glaxosmithkline GSK:US $ 6870M 1927M
GlaxoSmithKline GSK:LN 6.87B 1.93B
Intra Cellular Therapies ITCI:US $ 46.98M 14.14M
IONIS PHARMACEUT IONS:US $ 6.75M 19.37M
Karyopharm Therapeutics KPTI:US $ 23.48M 1.51M
Mirati Therapeutics MRTX:US $ 1.53M 0.28M
Neurocrine Biosciences NBIX:US $ 279M 15.5M
Novavax NVAX:US $ 194.53M 283.62M
Ptc Therapeutics PTCT:US $ 135.94M 5.34M
Regeneron Pharmaceuticals REGN:US $ 5161.4M 322.4M
Sarepta Therapeutics SRPT:US $ 230.28M 33.07M
Ultragenyx Pharmaceutical RARE:US $ 37.21M 8.84M
Vertex Pharmaceuticals VRTX:US $ 1332.9M 40.1M
YTE INCY:US $ 682.97M 120.62M